Ó£»¨ÊÓƵ

Skip to main content

Table 4 Characteristics of the care-patient-doctor system and antihypertensive drug in hypertensive patients followed at primary healthcare centers, Marrakech, 2021–2022

From: The silent struggle: assessing anxiety prevalence in Marrakech’s hypertensive population

Ìý

Total participants

n (%)

Self-reported anxiety n = 348

No self-reported anxiety n = 705

Patient-care system relationship

ÌýÌýÌý

 U²Ô²õ²¹³Ù¾±²õ´Ú²¹³¦³Ù´Ç°ù²â

873 (82.9)

314 (90.2)

559 (79.3)

â€ÇȲ¹³Ù¾±²õ´Ú²¹³¦³Ù´Ç°ù²â

180 (17.1)

34 (09.8)

146 (20.7)

Patient-doctor relationship

ÌýÌýÌý

 U²Ô²õ²¹³Ù¾±²õ´Ú²¹³¦³Ù´Ç°ù²â

866 (82.2)

293 (84.2)

573 (81.3)

â€ÇȲ¹³Ù¾±²õ´Ú²¹³¦³Ù´Ç°ù²â

187 (17.8)

55 (15.8)

132 (18.7)

Feel the doctor’s willingness to understand

the patient’s hypertension concerns

ÌýÌý

 N´Ç

507 (48.1)

201 (57.8)

306 (43.4)

 Y±ð²õ

546 (51.9)

147 (42 2)

399 (56.6)

Availability of the drug

ÌýÌýÌý

 N´Ç

637 (60.5)

258 (74.1)

379 (53.8)

 Y±ð²õ

416 (39.5)

90 (25.9)

326 (46.2)

Thinking you have a lot of drugs to take

ÌýÌý

 Y±ð²õ

40 (03.8)

22 (06.3)

18 (02.5)

 N´Ç

1013 (96.2)

326 (93.7)

687 (97.5)

Adverse drug effects

ÌýÌýÌý

 Y±ð²õ

263 (25.0)

107 (30.7)

156 (22.1)

 N´Ç

790 (75.0)

241 (69.3)

549 (77.9)

Non-purchase of a drug if it is out of stock

ÌýÌý

 Y±ð²õ

252 (23.9)

133 (38.2)

119 (16.9)

 N´Ç

801 (76.1)

215 (61.8)

586 (83.1)

Self-monitoring

ÌýÌýÌý

 N´Ç

849 (80.6)

294 (84.5)

555 (78.7)

 Y±ð²õ

204 (19.4)

54 (15.5)

150 (21.3)